• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.13% Nasdaq Up 0.14%

    More On DYAX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Dyax Corp. (DYAX)

    -NasdaqGM
    38.41 0.00(0.00%) Jan 21, 4:00PM EST
    Prev Close:38.41
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:32.58
    Beta:1.89139
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:14.06 - 38.56
    Volume:0
    Avg Vol (3m):3,617,440
    Market Cap:5.65B
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for DYAX

    Comparison

    Symbol% ChgMkt Cap
    DYAX 0.00%5.65B
    BCRXUp 4.62%266.77M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :N/A
    Quarterly EPS Est (Dec-15) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback